• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

What We’re Reading: HHS Investigating Change Cyberattack; Maternal Mortality Data Questioned; Drug Testing in Welfare

News
Article

The HHS Office for Civil Rights is investigating whether patient data were exposed in the cyberattack on Change Healthcare; a new study claims that the US’ high maternal mortality rates are the product of flawed data; HHS secretary is open to drug testing recipients of welfare.

HHS Opens Probe Into Privacy Impacts of Change Healthcare Cyberattack

The HHS Office for Civil Rights has opened an investigation into whether the cyberattack on Change Healthcare involved patients’ protected health information and whether the claims processor sufficiently protected patient privacy, according to the Associated Press. The attack in late February brought down the systems of Change Healthcare, a unit of UnitedHealth Group, wreaking havoc on billing and reimbursement, though the company said Wednesday that its major pharmacy and payment systems were back online. The Office for Civil Rights, which enforces federal privacy and security laws for patients’ health information, said its probe was spurred by the “unprecedented magnitude” of the ransomware attack.

Flawed Data to Blame for Apparent High Maternal Mortality Rates in US, Study Claims

New study findings could upend the notion that the US has an especially high and rising maternal mortality rate, claiming that the trend is a result of incorrectly classified data, The Hill reports. Published in the American Journal of Obstetrics & Gynecology, the study reports that deaths are considered maternal mortality events if the “pregnancy” box is checked on a death certificate, but this box was at times checked erroneously, including for hundreds of people older than 70 years. The researchers noted that despite the misclassified maternal deaths, racial and ethnic disparities in maternal mortality persist, including disproportionately high rates among Black women.

Amid Fentanyl Crisis, HHS Secretary Doesn’t Rule Out Drug Testing Welfare Recipients

Speaking at Politico’s Health Care Summit, HHS Secretary Xavier Becerra seemed open to the idea of requiring drug testing for recipients of welfare benefits. Considering the severity of the substance use epidemic, driven largely by fentanyl overdoses, Becerra said he wouldn’t dictate what actions cities, counties, or states should take; instead, all options should be left on the table. Such a measure was approved by San Francisco voters earlier this month, indicating how even heavily Democratic municipalities are turning to tougher policies to combat the tide of substance use.

Related Videos
Rashon Lane, PhD, MA
Dr Sophia Humphreys
Shawn Tuma, JD, CIPP/US, cybersecurity and data privacy attorney, Spencer Fane LLP
Ryan Stice, PharmD
Ronesh Sinha, MD
Pat Van Burkleo
Will Shapiro, vice president of data science, Flatiron Health
Pat Van Burkleo
dr mitzi joi williams
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.